Trevi Therapeutics, Inc. (TRVI) Financials

NASDAQ Currency in USD Disclaimer

$4.00

south_east -$0.06 (-1.48%)
Day's range
$3.96
Day's range
$4.14

TRVI Income statement / Annual

Last year (2023), Trevi Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Trevi Therapeutics, Inc.'s net income was -$29.07 M. See Trevi Therapeutics, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $123,000.00 $43,000.00 $50,000.00 $47,000.00 $39,000.00 $23,000.00 $0.00 $4,000.00
Gross Profit -$123,000.00 -$43,000.00 -$50,000.00 -$47,000.00 -$39,000.00 -$23,000.00 $0.00 -$4,000.00
Gross Profit Ratio 0 0 0 0 0 0 0 0
Research and Development Expenses $23.68 M $19.83 M $22.98 M $22.33 M $19.34 M $14.07 M $6.10 M $6.91 M
General & Administrative Expenses $9.95 M $10.07 M $9.49 M $10.16 M $7.31 M $4.34 M $2.14 M $1.66 M
Selling & Marketing Expenses $287,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $50,000.00
Selling, General & Administrative Expenses $10.24 M $10.07 M $9.49 M $10.16 M $7.31 M $4.34 M $2.14 M $1.71 M
Other Expenses $0.00 $719,000.00 -$375,000.00 -$287,000.00 $577,000.00 -$2.24 M -$24,000.00 $0.00
Operating Expenses $33.92 M $29.91 M $32.48 M $32.49 M $26.65 M $18.41 M $8.24 M $8.62 M
Cost And Expenses $33.92 M $29.91 M $32.48 M $32.49 M $26.65 M $18.41 M $8.24 M $8.63 M
Interest Income $4.75 M $1.74 M $10,000.00 $178,000.00 $792,000.00 $156,000.00 $69,000.00 $2.61 M
Interest Expense $391,000.00 $780,000.00 $1.20 M $456,000.00 $0.00 $174,000.00 $3.34 M $0.00
Depreciation & Amortization $123,000.00 $43,000.00 $50,000.00 $47,000.00 $39,000.00 $23,000.00 $4,000.00 $4,000.00
EBITDA -$33.80 M -$29.86 M -$32.43 M -$32.44 M -$26.61 M -$18.39 M -$8.19 M -$8.62 M
EBITDA Ratio 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $4.83 M $719,000.00 -$1.49 M -$287,000.00 $577,000.00 -$2.26 M -$4.65 M -$2.47 M
Income Before Tax -$29.10 M -$29.19 M -$33.96 M -$32.78 M -$26.07 M -$20.67 M -$12.89 M -$11.10 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0
Income Tax Expense -$32,000.00 -$36,000.00 -$21,000.00 -$18,000.00 -$18,000.00 -$124,000.00 -$26,000.00 -$8,000.00
Net Income -$29.07 M -$29.15 M -$33.94 M -$32.76 M -$26.05 M -$20.55 M -$12.86 M -$11.09 M
Net Income Ratio 0 0 0 0 0 0 0 0
EPS -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
EPS Diluted -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
Weighted Average Shares Out $99.03 M $64.54 M $22.84 M $18.06 M $11.74 M $8.97 M $8.97 M $16.14 M
Weighted Average Shares Out Diluted $99.03 M $64.54 M $22.84 M $18.06 M $11.74 M $8.97 M $8.97 M $16.14 M
Link